CDC Endorses COVID Boosters Targeting Omicron Variants : vim

Committee members somewhat reluctantly voted in support of new bivalent versions of COVID vaccines despite a lack of clinical trial data, citing the example of annual flu-shot revisions.

Related Keywords

New York , United States , California , Cayuga , Jamie Loehr , Pablo Sanchez , Dorit Reiss , Rochelle Walensky , Jason Roos , Sarah Long , Centers For Disease , University Of California Hastings College Law , Drexel University , Ohio State University , Drug Administration , Administration For Strategic Preparedness , Advisory Committee On Immunization Practices , Pfizer , Department Of Health Human Services , Products Advisory Committee , Disease Control , Director Rochelle Walensky , Advisory Committee , Immunization Practices , Cayuga Family Medicine , Related Biological Products Advisory Committee , California Hastings College , Distribution Already , Human Services , Strategic Preparedness , Response Element , Covid 19 Vaccine , Coronavirus Vaccine , Vaccine , Covid 19 Omicron Variant , Ovid 19 Omicronb 1 529 Variant , Ovid 19b 1 529 Variant , Ars Cov 2b 1 529 Variant , Ars Cov 2 Omicronb 1 529 Variant , Ars Cov 2 Omicron Variant , Ars Cov 2 Variantb 1 529 , Covid 19 Vaccination In Pediatrics , Ovid 19 Vaccination In Children , Ediatrics And Covid 19 Vaccination , Hildren And Covid 19 Vaccinati ,